Free tools Windows power users keep installed
One-click scans. No signup required.
iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
There is no automatic buy, hold, or sell signal in IREDA’s share-price fall. The decision depends on whether your investment thesis still holds, how much IREDA you own, and whether the share’s current valuation compensates you for its lending, funding, and capital risks. The available figures show a sharp decline alongside reported year-on-year growth, but they do not establish either a cause for the decline or that the stock is undervalued.
What the latest price and results do—and do not—show
In a market-data snapshot dated 6 October 2026, Upstox reported IREDA down 27.89% over one year, with a 52-week range of ₹107.40 to ₹158.70. Downstox reported an NSE close of about ₹109 that day. These are dated secondary-source figures, not a live quote; check current exchange data before acting.
Downstox also summarized Q1 FY27 revenue at about ₹2,236 crore, up 16.2% year on year, and net profit at about ₹339 crore, up 37.1%. Those figures are a secondary-source summary. Confirm the exact numbers and whether they are standalone or consolidated against IREDA’s filed Q1 FY27 results before relying on them. The company’s results archive lists Q1 FY 2026–27 results and presentations, and NSE filings include the company’s audited FY26 filings.
Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallEven if those growth figures are confirmed, revenue and profit growth alone do not establish the health or value of a lender. They do not answer whether asset quality, provisions, margins, funding costs, or capital needs are improving, nor whether the share price already reflects expected growth.
#1 Best Overall
Why might IREDA shares be falling?
The available evidence does not identify one authoritative cause for the full decline. A price chart records what happened; it does not prove why. Do not treat a particular result, government decision, fundraising plan, credit event, or management update as the cause unless a dated source directly connects it to the relevant share-price move.
Several factors are worth checking rather than assuming: a valuation can contract even while earnings rise; faster lending can bring greater credit and provisioning risk; funding costs can squeeze margins; and equity issuance can change per-share economics. These are possible contributors, not established explanations for IREDA’s fall. Check dated company results and exchange filings alongside market data before drawing a causal conclusion.
Rank #2
- Comes with secure packaging
- Easy to read text
- It can be a gift option
What to examine in IREDA as a renewable-energy lender
IREDA finances the renewable-energy sector, so investors should assess the quality and economics of its lending as well as the pace of growth. Look at the filed statements across comparable reporting periods, rather than inferring business health from the share price or headline profit growth.
- Asset quality and credit costs: Check gross and net non-performing assets (GNPA and NNPA), provisions, and credit costs. Assess whether changes reflect the broader loan book or individual borrowers.
- Margins and funding: Review net interest margin (NIM), spreads, borrowing costs, and funding mix. Lending growth is less valuable if funding becomes materially more expensive or margins weaken.
- Growth and capital: Compare loan-book growth and disbursements with capital adequacy, funding access, and any equity issuance or potential dilution. Growth needs adequate capital and sustainable funding.
- Valuation: Use a consistent valuation date and reporting period to assess price-to-book and earnings multiples. Compare them with a reasoned view of sustainable earnings and book value; neither the 52-week low nor a past high is, on its own, a fair-value estimate.
A specific historical disclosure merits attention without being generalized to the whole portfolio: IREDA’s financial statements filed with NSE stated that a borrower exposure of ₹783.34 crore outstanding as of 30 June 2025 was reclassified as an NPA (Stage III). The filing described falsified documents and IREDA’s finding of fraud. This is a reason to examine borrower-level and portfolio asset-quality disclosures, not proof that all IREDA loans carry the same risk.
Hold, buy more, or exit: a decision framework
| Choice | When it may fit | What to require before acting |
|---|---|---|
| Hold | Your original investment case remains intact and the holding still fits your time horizon, risk tolerance, and liquidity needs. | Verify the latest asset-quality, credit-cost, margin, funding, and capital figures. Decide in advance what deterioration would invalidate your thesis. |
| Buy more | You have a forward-looking valuation case and can accept the added portfolio concentration and downside risk. | Set a maximum position size and a valuation range first. Stress-test slower disbursements, higher provisions, costlier funding, and dilution. A lower quote alone is not a reason to add. |
| Exit or reduce | The thesis has broken, the position creates excessive risk, or the money has a better risk-adjusted use. | Base the choice on your investment case, portfolio needs, and risk limit—not solely on the fact that the price has fallen. Consider whether reducing rather than fully exiting better addresses the risk. |
How to compare IREDA with other investments
If you are choosing between IREDA, another lender, or a renewable-energy project developer, compare like with like: use the same valuation date and comparable reporting periods. A lender’s loan growth and credit risk are not directly interchangeable with a developer’s project, operating, and financing risks.
- For lenders, compare price-to-book and earnings multiples, loan-book growth, GNPA/NNPA, credit costs, NIM or spreads, cost of funds, capital adequacy, funding access, and dilution.
- For a project developer, assess its own business and financing risks rather than treating its performance as a proxy for IREDA’s lending book.
- Do not rely on a peer ranking or target price unless it is supported by comparable data and a clearly stated valuation method.
A practical check before placing an order
- Refresh the share quote and confirm the reporting period and basis of the latest filed results.
- Write down why you own—or would buy—IREDA, and what evidence would make that thesis no longer valid.
- Review asset quality, provisions, margins, funding costs, capital, and dilution in the filed statements.
- Check how the position fits your time horizon, cash needs, risk tolerance, and overall portfolio concentration.
- If considering an additional purchase, define your valuation range and maximum position size before comparing it with the market price.
The available figures support a decision process, not a personalized recommendation: they are not enough to establish a current fair value or conclude that the share is cheap.
Quick Recap
Best Value
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Clear out junk files and repair common Windows errorsFree Scan →
